1.
Bull Exp Biol Med
; 149(5): 612-4, 2010 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21165400
RESUMO
Anaferon (pediatric formulation) administered in the therapeutic-and-prophylactic regimen to mice receiving intranasally 100% infecting dose of A/California/07/2009(H1N1)v influenza virus exhibited an antiviral effect and 10-fold reduced the production of influenza virus in the lungs of infected mice on days 4, 6, and 8 after infection compared to the control (distilled water). The efficiency of Anaferon (pediatric formulation) administered before and after infection with A/California/07/2009(H1N1)v influenza virus was not inferior to the use of Tamiflu after infection.
Assuntos
Anticorpos/uso terapêutico , Antivirais/uso terapêutico , Infecções por Orthomyxoviridae/tratamento farmacológico , Animais , Vírus da Influenza A Subtipo H1N1/efeitos dos fármacos , Pulmão/virologia , Camundongos , Camundongos Endogâmicos BALB C , Infecções por Orthomyxoviridae/virologia , Oseltamivir/uso terapêutico
2.
FEBS Lett
; 115(1): 31-4, 1980 Jun 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7389916